Lv4
684 积分 2023-09-03 加入
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma
20小时前
已完结
ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
2天前
已关闭
Targeting the ATM–TGS1–BRCA1 Axis Overcomes Genotoxic Therapy Resistance in Pancreatic Adenocarcinoma
2天前
已完结
CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer
2天前
已完结
Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes
2天前
已完结
Deep contrastive learning enables genome-wide virtual screening
2天前
已完结
Targeting the DDX3/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma
2个月前
已完结
ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
2个月前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
2个月前
已完结
Single-nucleus DNA sequencing delves into the varied genomic evolution of pancreatic cancer
3个月前
已完结
皖公网安备34019202002308
